Leave Your Message
ADT1099-Blinatumomab Biosimilar– Anti-CD19, CD3E mAb – Research Grade
Hot

ADT1099-Blinatumomab Biosimilar– Anti-CD19, CD3E mAb – Research Grade

  • Catalog Number ADT1099
  • Host CHO Cells
  • Species Human
  • Target CD19/CD3E
  • Application Elisa, WB

CD3E (CD3 Epsilon Subunit Of T-Cell Receptor Complex) is a Protein Coding gene. Diseases associated with CD3E include Immunodeficiency 18 and T-B+ Severe Combined Immunodeficiency Due To Cd3delta/Cd3epsilon/Cd3zeta. Among its related pathways are Immune response NFAT in immune response and TCR Signaling (Qiagen). Gene Ontology (GO) annotations related to this gene include protein heterodimerization activity and obsolete signal transducer activity. An important paralog of this gene is CD3G.Part of the TCR-CD3 complex present on T-lymphocyte cell surface that plays an essential role in adaptive immune response. When antigen presenting cells (APCs) activate T-cell receptor (TCR), TCR-mediated signals are transmitted across the cell membrane by the CD3 chains CD3D, CD3E, CD3G and CD3Z. All CD3 chains contain immunoreceptor tyrosine-based activation motifs (ITAMs) in their cytoplasmic domain. 

Alpha Lifetech provides pre-sales and after-sales services for our products, and our blocking antibody solutions will provide technical support for your research.

Products Categories
Featured Products
recommended service
quick links
Contact Us

Product Background

CD3E (CD3E molecule) encodes the CD3-epsilon polypeptide and together with CD3 gamma, delta, zeta and somatic receptor alpha/beta or gamma/delta constitute the TCR-CD3 complex that plays a crucial role in T cell recognition and response to foreign antigens. The extracellular domain of CD3E contains an Ig-like domain, which allows it to be considered as part of the immunoglobulin superfamily. The cytoplasmic section of CD3E contains an immunoreceptor tyrosine activation motif (ITAM) that is a key structure for signal transduction.

Product Specification

Catalog Number

ADT1099

Product Name

ADT1099-Blinatumomab Biosimilar– Anti-CD19, CD3E mAb – Research Grade

Alias

AMG103, BITE MT-103

Isotype

(scFv Kappa-heavy)-(scFv-heavy Kappa)

Clonity

Monoclonal

Alternate Names

anti cd19, mouse cd19, mouse cd19 antibody, anti human cd19, anti-cd19, human cd19, cd19 antibody, anti cd19 antibody, cd19 recombinant antibody, cd19 blocking antibody, CD3E antibody, anti CD3E antibody, CD3E recombinant antibody, CD3E blocking antibody

Official Symbol

CD19/CD3E

Species

Human

Expression Host

CHO Cells

Reactivity

Mouse

Gene ID

930

CAS Number

853426-35-4

Chemical Formula

C2367H3577N649O772S19

Molecular Weight

54.10 KDa

Product Description

Blinatumomab is a bispecific CD19-directed CD3 T-cell engager that binds to CD19 expressed on the surface of cells of B-lineage origin and CD3 expressed on the surface of T cells. It activates endogenous T cells by connecting CD3 in the T-cell receptor  complex with CD19 on benign and malignant B cells. Blinatumomab mediates the formation of a synapse between the T cell and the tumor cell, upregulation of cell adhesion molecules, production of cytolytic proteins, release of inflammatory cytokines, and proliferation of T cells, which result in redirected lysis of CD19+ cells.

Mechanism of Action

Blinatumomab is a bispecific T-cell engager (BiTE) antibody that targets CD19 on B cells and CD3 on T cells.

Metabolism

The metabolic pathway of blinatumomab has not been characterized. Like other protein therapeutics, blinatumomab is expected to be degraded into small peptides and amino acids via catabolic pathways.

Size

1mg,5mg

Research Area

Cancer

Application

Elisa, WB

Purity

>95% as determined by SDS-PAGE

Concentration

Batch dependent

Buffer

Supplied in PBS, PH7.5

Storage

Store at -20 °C for 12 months. Store at -80 °C for long term storage.

Shipping Condition

Shipped on ice packs.

Note

This product is for research use only. 

Reference

1. Mikhailova E, et al. Cytometry B Clin Cytom, 2022 Sep. PMID 35796438
2. Shao L, et al. Sci Rep, 2022 Feb 18. PMID 35181722
3. Plaks V, et al. Blood, 2021 Sep 23. PMID 34041526

 

FAQ

Leave Your Message